Error in Figure - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to Figure 2A in the DROPROP Trial of Dexamethasone Eye Drops for Retinopathy of Prematurity

  • November 1, 2026

Share

Objective:

Report a correction to Figure 2A in the DROPROP randomized clinical trial.

Approach:
  • Correction: Figure 2A had incorrect bar heights and was corrected online.
Key Findings:
  • The corrected incidence of type 1 retinopathy of prematurity was 20% among dexamethasone recipients and 38% among placebo recipients.
Interpretation:

The correction updates the figure’s bar heights to reflect the reported incidence values.

Sources:

Original Source(s)

Error in Figure

  • November 1, 2026

Related Content

Pneumatic retinopexy identification in electronic medical records using an on-premises large language model

Data and Temporal Risk Concerns of Semaglutide and NAION

Pannus may recur after sodium amide eye injury

A 3-year case report documents delayed epithelial healing, repeated fibrovascular tissue growth, and unequal visual recovery following a bilateral chemical burn.